Introduction {#sec1-2055217316631762}
============

In Europe and North America the previously reported latitudinal gradient of incidence or prevalence for multiple sclerosis seems to have disappeared or decreased by comparison with prior published series of geographic data.^[@bibr1-2055217316631762][@bibr2-2055217316631762][@bibr3-2055217316631762]--[@bibr4-2055217316631762]^ In France, a previous study found a southwest-northeast gradient of prevalence in farmers,^[@bibr5-2055217316631762]^ and a subsequent study did not find such a gradient in employees.^[@bibr6-2055217316631762]^ Change in such a short period of time cannot be attributable to improvement in diagnosis accuracy or case ascertainment, nor to a change in environmental factors. Labour mobility might be of relevance, economic migrations in employees diluting the spatial repartition of multiple sclerosis susceptibility genes.^[@bibr4-2055217316631762]^ Geographic mobility for job search could have interfered with the gradient effect as migration at adulthood (for instance for professional reasons) may contribute to modifying multiple sclerosis prevalence where migrants have moved; the migrants may bring (or not bring) the latent disease along with them when moving at adulthood, as the risk of developing (or not developing) multiple sclerosis has already been largely determined by the age of 15 years.^[@bibr7-2055217316631762],[@bibr8-2055217316631762]^

In order to better describe the latitude gradient in France and to show that it is not uniform depending on the socioeconomic status of the studied population, we assessed whether the southwest-northeast gradient of multiple sclerosis that disappeared in employees, and that still exists in farmers, persists in another population which is also more sedentary than the employees: independent workers and their families.

Materials and methods {#sec2-2055217316631762}
=====================

Setting and target population {#sec3-2055217316631762}
-----------------------------

The health insurance fund for independent workers or *Régime Social des Indépendants* (RSI) is the third main statutory health insurance scheme in France. It is dedicated only to independent workers and their families (i.e. independent workers from small businesses in the manufacturing industry, craft industry and commercial industry, as well as workers from learned professions). It covers 6% of the French population, spread all over the French territory. French territory is divided in 101 French administrative areas called *départements* (named 'departments\' hereafter) including islands and overseas departments. Neighbouring departments are grouped into regions. The RSI covers all the departments and regions of the French territory. The target population was the population covered in the course of 2013.

Study type {#sec4-2055217316631762}
----------

Our study is a cross-sectional study carried out on two national databases based on the whole of France: TITAM. The administrative database of benefits in kind and in cash provided by the health insurance (named 'benefit\' hereafter).ARCHIMED. The medico-administrative database of the insured who are entitled, through health insurance, to exemption from their side copayment due to a long-term disease status granted by the French National Health Insurance System.^[@bibr3-2055217316631762]^

Statistical unit {#sec5-2055217316631762}
----------------

The statistical unit is the person who received the benefit. It is identified in the database by the insured person's single social security number and the beneficiary's ranking, if the person who received the benefit is not the actual insured person but one of their beneficiaries.

Included population {#sec6-2055217316631762}
-------------------

All persons who received a benefit in 2013 are included in the study, i.e. 4,165,903 persons.

Outcome {#sec7-2055217316631762}
-------

The outcome was the number of included persons who had, or had had, a long-term disease status^[a](#fn1-2055217316631762){ref-type="fn"}^ of multiple sclerosis granted by the French National Health Insurance System. Those persons are identified in the medico-administrative database of long-term disease status as having, or having had, multiple sclerosis, whatever the date of recognition as a long-term disease before 31 December 2013, even if the long-term disease agreement has not been renewed till this date (expired long-term disease agreements which are not renewed are kept in the medico-administrative database as long as the person is affiliated to RSI, even if they do not receive any benefit at all for years or decades after disease onset). Crude prevalence rates were calculated as the number of persons who received a benefit of any kind in 2013 and had, or had had, a long-term disease status for multiple sclerosis granted by the French National Health Insurance System per 100,000 persons who received a benefit of any kind in 2013.

We calculated the crude prevalence rates in each modality of the independent variables.

### Regional level (including islands and overseas departments) {#sec8-2055217316631762}

Pearson correlation was used to examine the relationship of crude prevalence rate and decimal degrees of north latitude (in absolute terms to take into account the southern hemisphere). Latitudes were those of capital cities of the 28 regions (*préfectures de region*).

### Departmental level (islands and overseas departments excluded) {#sec9-2055217316631762}

We applied the indirect method of standardisation: we calculated the expected number of cases in each department of France if they had the same age and sex-specific prevalence rates as the whole included population; then we divided the observed number of cases by the expected number of cases to provide the crude standardised morbidity ratio (SMR) in each department.

A spatial smoothing of the crude SMRs was performed accounting for differences in department size and their spatial correlation -- adjacent departments may not be independent as their inhabitants probably share the same risk factors for multiple sclerosis. To that purpose, a Bayesian model was used.^[@bibr9-2055217316631762]^ This spatial smoothing reassessed the local values: the smaller the number of observed cases in a department, the more the smoothed value was influenced by the national reference value. It also took into consideration a spatial component by borrowing strength from neighbouring departments using a contiguity matrix. The extent of smoothing was determined by the size of the crude SMR, its precision and the underlying relative risk distribution. Thus the extent of smoothing was totally determined by the data.^[@bibr10-2055217316631762]^

However this mapping method is most useful for capturing gradual regional changes in disease rates and is less useful in detecting abrupt localised changes indicative of clustering.^[@bibr11-2055217316631762]^ So, a SMR spatial association measurement was also implemented using the G statistic.^[@bibr12-2055217316631762]^ The G statistic (Getis-Ord Gi) identifies statistically significant spatial clusters of high values (hot spots) and low values (cold spots), highlighting the existence of spatial structures. To create a hot spot, the territory concerned with respectively high or low value of the SMR must be surrounded by other entities also associated with high or low values.

In addition, a multiple linear regression model (ordinary least squares (OLS)) was used to examine the relationship of crude SMR with latitude and longitude. Latitudes and longitudes were those of capital cities of the departments (*préfectures de département*). As an outlier the department of Lozère was excluded.

Independent variable (varying factors) {#sec10-2055217316631762}
--------------------------------------

Insured party's age in 2013 broken down by age groups.Insured party's gender: men, women.Insured party's domicile in 2013 broken down by department and region of France, with the decimal degrees of latitude and longitude of the capital cities of each department and region.

Statistical analysis tools {#sec11-2055217316631762}
--------------------------

ArcGIS 10.1 (which includes a graphical user interface application called ArcMap) for estimate of spatial structures and cartographic representations.^[@bibr9-2055217316631762][@bibr10-2055217316631762][@bibr11-2055217316631762]--[@bibr12-2055217316631762]^SAS 9.3 for data processing: calculation of standardised morbidity ratio, non-spatial and spatial smoothing (GLIMMIX procedure performs estimation and statistical inference for generalized linear mixed models or GLMMs).

Ethics {#sec12-2055217316631762}
------

The data were entirely anonymised before being sent for analysis to the research group.

For ethics purposes, the database study was approved by the Commission nationale de l\'informatique et des libertés (CNIL) (French Data Protection Authority) (dossier no. 342521, amendment 2) and the study protocol was approved by the in-house RSI committee responsible for the research.

Results {#sec13-2055217316631762}
=======

Description of the included population {#sec14-2055217316631762}
--------------------------------------

Demographic characteristics are shown in [Tables 1](#table1-2055217316631762){ref-type="table"} and [2](#table2-2055217316631762){ref-type="table"}. Table 1.Multiple sclerosis prevalence in France; 4,165,903 beneficiaries in 2013 including 4182 prevalent cases; crude prevalence rates by domicile region, age, and gender.Domicile regions sorted by increasing multiple sclerosis crude prevalence ratesCapital city of the regionDecimal degrees of north latitude of the capital city of the region in absolute termsIncluded population (*n* = 4,165,903)Included population with the long term disease status 'multiple sclerosis' (*n* = 4182)Crude prevalence rates per 100,000 personsGuyaneCayenne4.9224856800Not filled562500MayotteMamoudzou12.7809700Saint Pierre et MiquelonSaint Pierre46.7786100ReunionSaint-Denis20.920347,197919MartiniqueFort-de-France14.616119,446736GuadeloupeBasse-Terre17.302628,5821138CorseAjaccio41.919225,231211st quartile 83Languedoc-RoussillonMontpellier43.6108232,14420187Provence-Alpes-Cote d\'AzurMarseille43.2965427,06837989AquitaineBordeaux44.8378267,65924290Pays-de-LoireNantes47.2184229,91021292Rhone-AlpesLyon45.7640455,67242192Midi-PyreneesToulouse43.6047226,02921394Ile-de-FranceParis48.8566625,725626100AuvergneClermont-Ferrand45.777297,337100103LimousinLimoges45.833650,73553104Poitou-CharentesPoitiers46.5802133,370140105CentreOrléans47.9030150,436162108PicardieAmiens49.894195,044105110BretagneRennes48.1173226,053252111Haute-NormandieRouen49.443298,206113115BourgogneDijon47.3220105,5011283rd quartile 121Basse-NormandieCaen49.182997,892119122AlsaceStrasbourg48.573483,052102123Nord-pas-de-CalaisLille50.6293185,288236127LorraineMetz49.1193107,337139129Franche-ComteBesançon47.237866,72491136Champagne-ardenneChâlons-en-Champagne48.956770,064100143Age, yearsMean42.6952.44Standard deviation23.0214.25Median44.0052.00Minimum00Maximum1131010--136377384114--295448711813330--3954028161111340--49753382101013450--59671542103715460--6951088984516570--7926578235913580 and above24141813556GenderWomen17917712517140Men2374132166570[^1] Table 2.Multiple sclerosis prevalence in France; 4,165,903 beneficiaries in 2013 including 4182 prevalent cases; crude prevalence rates by domicile department.Included population (*n* = 4,165,903)Included population with the long term disease status 'multiple sclerosis' (*n* = 4182)Crude prevalence rates per 100,000 personsDomicile department sorted by increasing multiple sclerosis crude prevalence rates (zip-code and name)973Guyane856800975Saint Pierre et Miquelon100976Mayotte700Not filledNot filled562500974Reunion47,197919972Martinique19,446736971Guadeloupe28,582113811Aude30,735134253Mayenne18,037126713Bouches du Rhone135,382936982Tarn et Garonne20,239146932Gers15,6491110th percentile 7073Savoie39,580287140Landes31,520237365Hautes Pyrenees18,84415807Ardeche24,784208179Deux Sevres23,470198163Puy de Dome43,224358126Drome37,721318234Herault95,182798320Corse25,231218364Pyrenees Atlantiques53,471458424Dordogne37,866328549Maine et Loire47,228408538Isere81,585708692Hauts de Seine85,618748612Aveyron24,035218793Seine Saint Denis60,083538819Correze18,04916891Ain37,962349072Sarthe30,096279030Gard60,747559131Haute Garonne89,346829280Somme28,12426929Ariege12,772129495Val d\'Oise49,529479554Meurthe et Moselle35,504349674Haute Savoie64,592629684Vaucluse47,917469633Gironde118,2961149683Var101,538989766Pyrenees Orientales39,325389756Morbihan57,544569744Loire Atlantique86,84085986Alpes Maritimes113,1971119878Yvelines66,721669994Val de Marne66,0716610071Saone et Loire37,0283710085Vendee47,7094810128Eure et Loir22,734231014Alpes de Haute Provence14,7951510145Loiret36,2573710255Meuse97651010269Rhone117,86612210437Indre et Loire36,6523810410Aube16,3081710442Loire51,5825410516Charente26,7452810577Seine et Marne64,6566810547Lot et Garonne26,5062810687Haute Vienne23,6382510660Oise40,4534310675Paris180,43619210650Manche32,7403510758Nievre13,7601510935Ille et Vilaine65,3637211017Charente Maritime56,6426311115Cantal12,528141125Hautes Alpes14,2391611276Seine Maritime63,9447211386Vienne26,5133011318Cher19,4012211391Essonne52,6116011481Tarn29,7683411436Indre13,9751611468Haut Rhin32,083371158Ardennes15,5971811559Nord116,07013411529Finistere58,6816811670Haute Saone14,497171173Allier24,2492912027Eure34,2624112041Loir et Cher21,4172612161Orne19,0902412622Cotes d\'Armor44,4655612643Haute Loire17,3362212767Bas Rhin50,9696512814Calvados46,0626013023Creuse90481213321Cote d\'Or32,704441352Aisne26,4673613639Jura16,8172390th percentile 13790Territoire de Belfort6356914225Doubs29,0544214589Yonne22,0093214562Pas de Calais69,21810214752Haute Marne94571414857Moselle38,6295815046Lot15,3762415688Vosges23,4393715851Marne28,7025117848Lozere615516260[^2]

The included population was made up of 4,165,903 persons of which 4182 had or had had a long term disease status for multiple sclerosis granted by the French National Health Insurance System. Their mean age was 42.69 years (standard deviation (SD) 23.02) and 52.44 years (SD 14.25) with 43.01% and 60.19% of women respectively. They were living in 28 regions and 101 departments. The smallest region (which is also a department) was Saint Pierre And Miquelon (one person; 0.00%) and the largest region was Ile-De-France (625,725 persons; 15.02%); the largest department was Paris (180,436 persons; 4.33%) ([Tables 1](#table1-2055217316631762){ref-type="table"} and [2](#table2-2055217316631762){ref-type="table"}).

Multiple sclerosis prevalence in the included population {#sec15-2055217316631762}
--------------------------------------------------------

### Crude prevalence rates {#sec16-2055217316631762}

Among RSI beneficiaries, multiple sclerosis national prevalence in France in 2013 was 4182 cases for 4,165,903 beneficiaries regardless of age, i.e. 100.39/100,000 beneficiaries (95% confidence interval (CI): 97.39--103.47), 140.48/100,000 beneficiaries in women (95% CI: 135.10--146.07) and 70.13/100,000 beneficiaries in men (95% CI: 66.84--73.58).

The prevalence rates according to age and sex are shown in [Figure 1](#fig1-2055217316631762){ref-type="fig"}. Figure 1.Multiple sclerosis prevalence in France; 4,165,903 beneficiaries in 2013 including 4182 prevalent cases; crude prevalence rates per 100,000 persons by age and gender.Source: Health insurance fund for independent workers -- whole of France.

RSI population size, crude prevalence rate, and decimal degrees of latitude in absolute terms for each of the 28 regions of the French territory are given in [Table 1](#table1-2055217316631762){ref-type="table"}. Latitude (in absolute terms to take into account the southern hemisphere) was strongly correlated with crude prevalence rate (*r* = 0.68, *p* \< 0.0001) in the 28 regions.

Regions where multiple sclerosis prevalence was below the 1^st^ quartile (84.91/100,000) and regions where multiple sclerosis prevalence was above the 3^rd^ quartile (118.20/100,000) are shown in [Table 1](#table1-2055217316631762){ref-type="table"}.

Departments where multiple sclerosis prevalence was equal or below the 10^th^ percentile (70.29/100,000) and departments where multiple sclerosis prevalence was equal or above the 90^th^ percentile (136.77/100,000) are shown in [Table 2](#table2-2055217316631762){ref-type="table"}.

### SMR {#sec17-2055217316631762}

The following analyses were performed excluding islands and overseas departments.

We mapped the crude SMRs at the French department level ([Figure 2(a)](#fig2-2055217316631762){ref-type="fig"}). Figure 2.Multiple sclerosis standardised prevalence ratio for each department of France; 4,165,903 beneficiaries in 2013 including 4182 prevalent cases: (a) crude standardised morbidity ratios (SMRs); (b) smoothed SMRs. Islands and overseas departments are not shown.Source: Health insurance fund for independent workers -- whole of France.

The Bayesian spatial smoothing of the crude SMRs captured the gradual regional changes in disease rates, revealing an obvious southwest/northeast gradient that visually clearly appeared when the smoothed SMRs were mapped ([Figure 2(b)](#fig2-2055217316631762){ref-type="fig"}).

Two spatial structures with similar levels of SMR, were highlighted in [Figure 3](#fig3-2055217316631762){ref-type="fig"}: a spatial cluster of low values (cold spots with a GiZScore below --2.58 SD) in the southwest for Haute Garonne and Gers and a spatial cluster of high values (hot spots with a GiZScore above + 2.58 SD) in the northeast for Territoire de Belfort, Haute Saone, Haute Marne and Aube. Figure 3.Multiple sclerosis standardised prevalence ratio for each department of France; 4,165,903 beneficiaries in 2013 including 4182 prevalent cases. Standardised morbidity ratio (SMR) spatial association measurement using the G statistic detecting spatial disease clustering (islands and overseas departments are not shown).Source: Health insurance fund for independent workers -- whole of France.

Confirming the visual approach, the OLS multiple linear regression model showed the existence of a south-north effect and a west-east side effect. Crude SMR was correlated with latitude (*p* \< 0.0001) and with longitude (*p* = 0.0031) in the departments of France: adjusted *R*^2 ^= 0.3038; regression equation: $${\text{SMRpredicted} = - 1.618 + 0.056 \times \text{latitude}}{{\quad\quad\quad} + 0.023 \times \text{longitude}}$$

The OLS simple linear regression model, assessing the association of crude SMR with latitude, highlights the south-north effect: *p* \< 0.0001; adjusted *R*^2 ^= 0.2408; regression equation: $$\text{SMRpredicted} = - 1.476 + 0.054 \times \text{latitude}$$

[Figure 4](#fig4-2055217316631762){ref-type="fig"} shows the model fit and summarises some of the statistics. Figure 4.Fit plot showing the model fit and summarising some of the statistics, for the simple linear regression model assessing the association of multiple sclerosis standardised prevalence ratio (SMR) with latitude (degrees north, based on prefecture cities), for each department of France (islands and overseas departments excluded).Source: Health insurance fund for independent workers -- whole of France.

Discussion {#sec18-2055217316631762}
==========

Analysing 4,165,903 independents workers and their families out of the 65,543,000 inhabitants of France (6%), our study completes the two previous French studies carried out in farmers and in employees (respectively 5% and 87% of the French population) and thus gives a complete overview of multiple sclerosis prevalence in France.^[@bibr5-2055217316631762],[@bibr6-2055217316631762]^

Accounting for the age, sex, size difference and autocorrelation between geographic entities our study found a latitudinal gradient of prevalence in the population of independents workers and their families, similarly to that which was found for farmers and their families,^[@bibr5-2055217316631762]^ but contrary to findings for employees and their families.^[@bibr6-2055217316631762]^ Three explanations can be proposed for the modification of the gradient effect in employees: compared to the other two populations, they are (a) younger, which implies that the onset of the disease is more recent; (b) more prone to move for professional reasons ([Figure 5](#fig5-2055217316631762){ref-type="fig"}) as farmers are attached to their land and independents can create their own employment locally (geographic mobility in adulthood interferes with the gradient effect);^[@bibr4-2055217316631762]^ and (c) less exposed to outdoor work (ultraviolet (UV) radiation gradient over France also interferes).^[@bibr13-2055217316631762][@bibr14-2055217316631762][@bibr15-2055217316631762][@bibr16-2055217316631762]--[@bibr17-2055217316631762]^ Figure 5.Departmental mobility of French populations according to their status (farmer, independent worker, employee).Source: Institut national de la statistique et des études économiques (INSEE), 2008.

Moreover our study found a geographic clustering of the disease similar to that which was already found by Kurtzke and Delasnerie-Lauprêtre in 1986, indicating geographic stability of the clusters over time.^[@bibr18-2055217316631762]^ It is therefore unlikely that the observed change in geography of multiple sclerosis for the population of employees in France was due to a change in an environmental factor as it would have affected the independent and agricultural workers populations in the same way. Nor can it be due to a difference in the level of disease investigation or a better accuracy in the survey methodology, as the same methods of case ascertainment have been used. Geographic mobility for job search or other professional reasons could have diluted the geographical repartition of prevalent cases in the population of employees.

In our study, the six departments with the lowest multiple sclerosis crude prevalence rates are islands or overseas departments. They present a high rate of inhabitants born outside metropolitan France, a high amount of sunshine, and the smallest numeric values of degrees of latitude in absolute terms (excluding Saint Pierre and Miquelon) ([Table 1](#table1-2055217316631762){ref-type="table"}). This was not unexpected, given the lower frequencies of high-risk alleles for multiple sclerosis (e.g. In the human leukocyte antigen (HLA) class II group of genes, statistically, an association of multiple sclerosis with the HLA-DRB1\*15:01-HLA-DQB1\*06:02 haplotype has been demonstrated in northern European populations. Multiple sclerosis in African populations is characterized by greater haplotypic diversity and distinct patterns of linkage disequilibrium compared with northern Europeans.) in non-European-descent populations, the link between sun exposure and prevalence, and the significant positive correlation between latitude and prevalence worldwide.^[@bibr13-2055217316631762][@bibr14-2055217316631762][@bibr15-2055217316631762][@bibr16-2055217316631762]--[@bibr17-2055217316631762],[@bibr19-2055217316631762]^

In the study on salaried workers, the two regions with the lowest smoothed relative risk of multiple sclerosis prevalence (i.e. Ile de France and Provence Alpes Côte d'Azur) present a high non-Caucasian population share.^[@bibr4-2055217316631762],[@bibr6-2055217316631762]^ A study conducted in the UK found the lowest multiple sclerosis prevalence rates in geographic areas where the non-UK born population share was the highest.^[@bibr20-2055217316631762]^

A potential relationship between past exposure to sun and risk of multiple sclerosis has been observed by a number of authors.^[@bibr13-2055217316631762][@bibr14-2055217316631762][@bibr15-2055217316631762][@bibr16-2055217316631762]--[@bibr17-2055217316631762]^ So if multiple sclerosis was due to both genetics and environmental factors before adulthood,^[@bibr7-2055217316631762],[@bibr21-2055217316631762]^ it would be of interest to be aware of each patient\'s birth place, besides their residence, in order to diminish the impact of migration flows on the geographic gradient; this could be the subject of another study.

To compare our findings with other results in the literature, it is important to note that there are two different types of studies: those using primary data from medical records, and those, as in our study, using secondary administrative data.

The first type of studies estimated multiple sclerosis prevalence to be (a) between 128 and 171/100,000 in Brittany^[@bibr22-2055217316631762]^ (vs 132/100,000 in our study), (b) 188.2/100,000 in Lorraine^[@bibr23-2055217316631762]^ (vs 153/100,000 in our study), and (c) between 110 and 149/100,000 in Haute Garonne^[@bibr24-2055217316631762]^ (vs 109/100,000 in our study). The second type of study estimated multiple sclerosis prevalence to be (a) 65/100,000 in France in agricultural workers^[@bibr5-2055217316631762]^ (vs 100.39/100,000 in our study) and (b) 94/100,000 in France in employees^[@bibr6-2055217316631762]^ (vs 100.39/100,000 in our study). By comparing results from our study to these two previous studies using the same type of administrative data, there appears to be a temporal increase in multiple sclerosis prevalence although the increase observed could also be related to differences in the analysed populations.

Some authors reckon that at disease onset, during a period of a few months to several decades, disability results from focal inflammation (so that during this period of time immunomodulatory drugs are effective against disability). Thereafter, whatever the duration of this first phase, a diffuse degenerative process takes over for approximately seven years, with progression of irreversible disability (still with no therapeutic hope but for which treatments, to protect from neurodegeneration and enhance repair, are in phase III of clinical research).^[@bibr25-2055217316631762][@bibr26-2055217316631762][@bibr27-2055217316631762][@bibr28-2055217316631762]--[@bibr29-2055217316631762]^ Multiple sclerosis cases in our study are taken into account in the two phases of the disease, since recognition as a long-term disease status, with entitlement to exemption of copayment, requires either being treated with immunomodulatory drugs or permanent disability.^[b](#fn2-2055217316631762){ref-type="fn"}^ Although we could not determine individually to which phase of the disease our cases belonged, nevertheless we observed the highest relative frequency of prevalent cases, for women, in the 50--59 year-old age class and, for men, in the 60--69 year-old age class, which corresponds respectively to the median age to reach Kurtzke Disability Status Scale^[c](#fn3-2055217316631762){ref-type="fn"}^ (DSS) level of DSS 6 (women) and DSS 7 (men) according to the literature^[@bibr30-2055217316631762]^ ([Figure 1](#fig1-2055217316631762){ref-type="fig"}), two scores corresponding to the second phase of the disease (diffuse neurodegenerative process).^[@bibr25-2055217316631762],[@bibr26-2055217316631762]^

Limitations of the current approach {#sec19-2055217316631762}
-----------------------------------

The current approach, using claims by the insured party for recognition of a long term disease status, may have ignored clinically isolated syndromes as long as they do not respond to the administrative definition of a long term disease entitling to exemption of co-payment by the insured party.^[@bibr2-2055217316631762]^ However, given that multiple sclerosis in itself, by its own natural history alone, entirely responds to the definition of a long term disease, as soon as a clinically definite multiple sclerosis has developed, the chances are high that the claim was made by the insured party; if so, whatever the clinical course of the disease at that time, this claim would have been immediately granted by RSI, even if it is a newly diagnosed case, since the disease is deemed to be a long-term disease and considered as such by the RSI.

Insured parties who did not perceive any benefit at all during the whole year 2013 were not included in our study (neither in the numerator nor in the denominator). It was assumed that they did not represent a significant part of the population affiliated to the health insurance system as benefits cover the entire spectrum of care, even for the most common diseases.

Given the risk of ecological fallacy, ecological data such as mobility, as a group, of farmers, employees, or independents, are limited in their ability to postulate conclusions at the individual level.

Conclusion {#sec20-2055217316631762}
==========

In France, in more sedentary and more exposed to outdoor work populations than employees, like farmers and independent workers, the north-south gradient of multiple sclerosis still exists while it has disappeared in employees. If we admit that the risk of developing multiple sclerosis is determined during childhood or adolescence and is not associated with socioeconomic status by itself,^[@bibr31-2055217316631762],[@bibr32-2055217316631762]^ our findings support the assumption that geographic mobility for job search or for professional reasons at adulthood could influence the latitudinal gradient of prevalence for multiple sclerosis. The findings suggest that labour mobility could play a role in altering the north-south gradient that exists in France and more broadly that migrations could explain the recent observations of disappearance or decrease of the north-south gradient of multiple sclerosis in Europe and North America.

The authors would like to thank the RSI board for providing them with access to claims data to conduct this research, as well as members of the Support Group to Methods and Dissemination of Health Studies. The opinions expressed by authors do not necessarily reflect those of RSI.

Decree n°2011\--77 of January 19^th^ 2011 updating the list and medical criteria used for the definition of diseases giving right to the exemption of copayment by the insured party (JORF n°0017 of January 21^st^ 2011 page 1287 text n° 20) ; medical criteria used for the definition of the long term disease 'multiple sclerosis'. Multiple sclerosis is subject to the exemption of copayment by the insured party --- when a disease-modifying immunomodulatory drug is being prescribed as the outcome of the medical check-up, even in the absence of permanent disability; --- in case of a permanent disability (sometimes only consisting in asthenia or cognitive disturbances) requiring symptomatic treatment and justifying long term treatment) Initial exemption of copayment is given for 5 years, extendable.

Decree n°2011-77 of January 19^th^ 2011 updating the list and medical criteria used for the definition of diseases giving right to the exemption of copayment by the insured party (JORF n°0017 of January 21^st^ 2011 page 1287 text n° 20); medical criteria used for the definition of the long term disease 'multiple sclerosis'. Multiple sclerosis is subject to the exemption of copayment by the insured party --- when a disease-modifying immunomodulatory drug is being prescribed as the outcome of the medical check-up, even in the absence of permanent disability; --- in case of a permanent disability (sometimes only consisting in asthenia or cognitive disturbances) requiring symptomatic treatment and justifying long term treatment) Initial exemption of copayment is given for 5 years, extendable.

Kurtzke Disability Status Scale (DSS). Kurtzke scale is used to determine MS disability status. A score of 4 shows a limited walking ability but without aid or rest of more than 500m. A score of 6 shows the ability to walk with unilateral support no more than 100m without rest. A score of 7 shows the ability to walk no more than 10m without rest while leaning against a wall or holding onto furniture for support. Later on, an expanded disability status scale (EDSS) has been implemented (Kurtzke, 1983).
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[^1]: Source: Health insurance fund for independent workers -- whole of France.

[^2]: Source: Health insurance fund for independent workers -- whole of France.
